126 related articles for article (PubMed ID: 8187933)
1. Time-course study of 1,25-(OH)2-vitamin D3 induction of homologous receptor and c-myc in nontransformed and transformed C3H/10T1/2 cell clones.
Paatero GI; Trydal T; Karlstedt KA; Aarskog D; Lillehaug JR
Int J Biochem; 1994 Mar; 26(3):367-74. PubMed ID: 8187933
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1,25-(OH)2-vitamin D3 on growth, homologous receptor and c-myc regulation in C3H/10T1/2 cells.
Trydal T; Lillehaug JR; Aksnes L; Aarskog D
Mol Cell Endocrinol; 1990 Dec; 74(3):191-202. PubMed ID: 1965647
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cell growth, c-myc mRNA, and 1,25-(OH)2 vitamin D3 receptor in C3H/10T1/2 mouse embryo fibroblasts by calcipotriol and 1,25-(OH)2 vitamin D3.
Trydal T; Lillehaug JR; Aksnes L; Aarskog D
Acta Endocrinol (Copenh); 1992 Jan; 126(1):75-9. PubMed ID: 1310564
[TBL] [Abstract][Full Text] [Related]
4. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones.
Taoka T; Collins ED; Irino S; Norman AW
Mol Cell Endocrinol; 1993 Sep; 95(1-2):51-7. PubMed ID: 8243807
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cell proliferation and cell cycle, and inhibition of cytokinesis by 1,25-dihydroxyvitamin D3 in C3H/10T1/2 fibroblasts.
Brackman D; Lillehaug JR; Aksnes L; Aarskog D
J Steroid Biochem Mol Biol; 1993 Aug; 46(2):155-62. PubMed ID: 8664163
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
[TBL] [Abstract][Full Text] [Related]
8. Absence of PDGF-induced, PKC-independent c-fos expression in a chemically transformed C3H/10T1/2 cell clone.
Vassbotn FS; Skar R; Holmsen H; Lillehaug JR
Exp Cell Res; 1992 Sep; 202(1):98-104. PubMed ID: 1380924
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes.
Sølvsten H; Svendsen ML; Fogh K; Kragballe K
Arch Dermatol Res; 1997 May; 289(6):367-72. PubMed ID: 9209684
[TBL] [Abstract][Full Text] [Related]
10. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
Yao J; Kathpalia P; Bushinsky DA; Favus MJ
J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor.
Koeffler HP; Bishop JE; Reichel H; Singer F; Nagler A; Tobler A; Walka M; Norman AW
Mol Cell Endocrinol; 1990 Mar; 70(1):1-11. PubMed ID: 2160380
[TBL] [Abstract][Full Text] [Related]
12. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs.
Musiol IM; Feldman D
Endocrinology; 1997 Jan; 138(1):12-8. PubMed ID: 8977379
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
14. Reorganization of the cytoskeleton and morphological changes induced by 1,25-dihydroxyvitamin D3 in C3H/10T1/2 mouse embryo fibroblasts: relation to inhibition of proliferation.
Brackman D; Trydal T; Lillehaug JR; Aarskog D
Exp Cell Res; 1992 Aug; 201(2):485-93. PubMed ID: 1639143
[TBL] [Abstract][Full Text] [Related]
15. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
[TBL] [Abstract][Full Text] [Related]
16. Differentiation-related regulation of 1,25-dihydroxyvitamin D3 receptor mRNA in human leukaemia cells HL-60.
Pan P; Reddy K; Lee S; Studzinski GP
Cell Prolif; 1991 Mar; 24(2):159-70. PubMed ID: 1849022
[TBL] [Abstract][Full Text] [Related]
17. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T
Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190
[TBL] [Abstract][Full Text] [Related]
18. Growth control of human colon-adenocarcinoma-derived Caco-2 cells by vitamin-D compounds and extracellular calcium in vitro: relation to c-myc-oncogene and vitamin-D-receptor expression.
Hulla W; Kállay E; Krugluger W; Peterlik M; Cross HS
Int J Cancer; 1995 Sep; 62(6):711-6. PubMed ID: 7558419
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activities of 2 beta-chloro-, 2 beta-fluoro-, and 2 beta-methoxy-1 alpha,25-dihydroxyvitamin D3.
Scheddin D; Mayer H; Schönecker B; Gliesing S; Reichenbächer M
Steroids; 1998 Dec; 63(12):633-43. PubMed ID: 9870260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
